|
HAUS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.432000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.006200E-02 |
| Normal-vs-Stage2 |
9.158600E-04 |
| Normal-vs-Stage3 |
1.254770E-01 |
| Normal-vs-Stage4 |
1.395020E-03 |
| Stage1-vs-Stage2 |
1.924110E-02 |
| Stage1-vs-Stage3 |
9.985800E-01 |
| Stage1-vs-Stage4 |
4.957800E-02 |
| Stage2-vs-Stage3 |
3.735600E-02 |
| Stage2-vs-Stage4 |
6.964000E-01 |
| Stage3-vs-Stage4 |
7.574300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.005500E-02 |
| Normal-vs-AfricanAmerican |
5.995600E-02 |
| Normal-vs-Asian |
2.500800E-01 |
| Caucasian-vs-AfricanAmerican |
6.399000E-01 |
| Caucasian-vs-Asian |
5.482400E-01 |
| AfricanAmerican-vs-Asian |
3.475400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.148300E-02 |
| Normal-vs-Female |
2.678000E-02 |
| Male-vs-Female |
8.520200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.466780E-01 |
| Normal-vs-Age(41-60Yrs) |
2.178400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.404500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.781400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.809800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.034200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.688200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.287190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.615400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.479800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.247600E-01 |
| Classical-VS-Follicular |
1.715700E-02 |
| Classical-VS-Other |
2.625200E-01 |
| Classical-VS-Normal |
9.627600E-02 |
| Tall-VS-Follicular |
2.607200E-01 |
| Tall-VS-Other |
3.070200E-01 |
| Tall-VS-Normal |
1.763600E-01 |
| Follicular-VS-Other |
1.196950E-01 |
| Follicular-VS-Normal |
1.841640E-03 |
| Other-VS-Normal |
6.801000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.137680E-02 |
| Normal-vs-N1 |
2.720100E-02 |
| N0-vs-N1 |
9.370800E-01 |
|
|
